Suppr超能文献

评估不明甲状腺结节甲状腺切除术的范围:肿瘤学视角。

GAUGING THE EXTENT OF THYROIDECTOMY FOR INDETERMINATE THYROID NODULES: AN ONCOLOGIC PERSPECTIVE.

出版信息

Endocr Pract. 2017 Apr 2;23(4):442-450. doi: 10.4158/EP161540.OR. Epub 2017 Jan 17.

Abstract

OBJECTIVE

Increasing emphasis is being placed on appropriateness of care and avoidance of over- and under-treatment. Indeterminate thyroid nodules (ITNs) present a particular risk for this problem because cancer found via diagnostic lobectomy (DL) often requires a completion thyroidectomy (CT). However, initial total thyroidectomy (TT) for benign ITN results in lifelong thyroid hormone replacement. We sought to measure the accuracy and factors associated with the extent of initial thyroidectomy for ITN.

METHODS

We queried a single institution thyroid surgery database for all adult patients undergoing an initial operation for ITN. Multivariate logistic regression identified factors associated with either oncologic under- or overtreatment at initial operation.

RESULTS

There were 639 patients with ITN. The median age was 52 (range, 18 to 93) years, 78.4% were female, and final pathology revealed a cancer >1 cm in 24.7%. The most common cytology was follicular neoplasm (45.1%) followed by Hürthle cell neoplasm (20.2%). CT or initial oncologic undertreatment was required in 58 patients (9.3%). Excluding those with goiters, 19.0% were treated with TT for benign final pathology. Multivariate analysis failed to identify any factor that independently predicted the need for CT. Female gender was associated with TT in benign disease (odds ratio [OR], 2.1; 95% confidence interval [CI], 1.0 to 4.5; P = .05). Age >45 years predicted correct initial use of DL (OR, 2.6; 95% CI, 1.2 to 5.7; P = .02). Suspicious for papillary thyroid carcinoma (OR, 5.7; 95% CI, 2.1 to 15.3; P<.01) and frozen section (OR, 9.7; 95% CI, 2.5 to 38.6; P<.01) were associated with oncologically appropriate initial TT. The highest frequency of CT occurred in patients with follicular lesion of undetermined significance (11.6%). TT for benign final pathology occurred most frequently in patients with a Hürthle cell neoplasm (24.8%).

CONCLUSION

In patients with ITN, nearly 30% received an inappropriate extent of initial thyroidectomy from an oncologic standpoint. Tools to pre-operatively identify both benign and malignant disease can assist in the complex decision making to gauge the proper extent of initial surgery for ITN.

ABBREVIATIONS

ATA = American Thyroid Association AUS = atypia of undetermined significance CI = confidence interval CT = completion thyroidectomy FLUS = follicular lesion of undetermined significance ITN = indeterminate thyroid nodule OR = odds ratio PTC = papillary thyroid carcinoma TT = total thyroidectomy.

摘要

目的

人们越来越重视医疗的适宜性,避免过度治疗和治疗不足。不确定的甲状腺结节(ITN)特别存在这个问题的风险,因为通过诊断性甲状腺叶切除术(DL)发现的癌症通常需要完成甲状腺切除术(CT)。然而,对良性 ITN 进行初始全甲状腺切除术(TT)会导致终身甲状腺激素替代治疗。我们旨在衡量初始甲状腺切除术治疗 ITN 的准确性和相关因素。

方法

我们对一家机构的甲状腺手术数据库进行了查询,以确定所有接受初始 ITN 手术的成年患者。多变量逻辑回归确定了初始手术中与肿瘤治疗不足或过度治疗相关的因素。

结果

共有 639 例 ITN 患者。中位年龄为 52 岁(范围为 18 至 93 岁),78.4%为女性,最终病理显示癌症>1cm 占 24.7%。最常见的细胞学类型是滤泡性肿瘤(45.1%),其次是 Hurthle 细胞肿瘤(20.2%)。58 例(9.3%)需要 CT 或初始肿瘤治疗不足。不包括甲状腺肿患者,19.0%的良性最终病理采用 TT 治疗。多变量分析未能确定任何可独立预测 CT 需求的因素。女性是良性疾病中 TT 的相关因素(比值比[OR],2.1;95%置信区间[CI],1.0 至 4.5;P=0.05)。年龄>45 岁预测 DL 的初始使用正确(OR,2.6;95%CI,1.2 至 5.7;P=0.02)。可疑甲状腺乳头状癌(OR,5.7;95%CI,2.1 至 15.3;P<0.01)和冷冻切片(OR,9.7;95%CI,2.5 至 38.6;P<0.01)与肿瘤学上适当的初始 TT 相关。滤泡性意义未确定病变(11.6%)患者的 CT 发生率最高。良性最终病理的 TT 最常发生在 Hurthle 细胞肿瘤患者(24.8%)。

结论

在 ITN 患者中,近 30%的患者从肿瘤学角度来看,初始甲状腺切除术的范围不合适。术前识别良性和恶性疾病的工具可以帮助我们在复杂的决策中评估 ITN 的初始手术的适当范围。

相似文献

1
GAUGING THE EXTENT OF THYROIDECTOMY FOR INDETERMINATE THYROID NODULES: AN ONCOLOGIC PERSPECTIVE.
Endocr Pract. 2017 Apr 2;23(4):442-450. doi: 10.4158/EP161540.OR. Epub 2017 Jan 17.
2
Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
J Am Coll Surg. 2017 Jul;225(1):77-82. doi: 10.1016/j.jamcollsurg.2017.02.002. Epub 2017 Feb 20.
3
Thyroid lobectomy for indeterminate FNA: not without consequences.
J Surg Res. 2013 Sep;184(1):189-92. doi: 10.1016/j.jss.2013.05.076. Epub 2013 Jun 11.
4
Reasons Associated with Total Thyroidectomy as Initial Surgical Management of an Indeterminate Thyroid Nodule.
Ann Surg Oncol. 2018 May;25(5):1410-1417. doi: 10.1245/s10434-018-6421-x. Epub 2018 Mar 8.
5
Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Cytopathology. 2013 Dec;24(6):385-90. doi: 10.1111/cyt.12021. Epub 2012 Oct 18.
6
Trends and Outcomes of Surgical Management of Primary Papillary Carcinoma in the Pediatric Population.
J Surg Res. 2021 Jul;263:207-214. doi: 10.1016/j.jss.2021.01.043. Epub 2021 Mar 6.
10
Incidence and malignancy rates of indeterminate pediatric thyroid nodules.
Cancer Cytopathol. 2019 Apr;127(4):231-239. doi: 10.1002/cncy.22104. Epub 2019 Feb 15.

引用本文的文献

1
Completion Thyroidectomy Trends and Rates: A Systematic Review and Meta-Analysis.
Clin Otolaryngol. 2025 Mar;50(2):205-219. doi: 10.1111/coa.14262. Epub 2024 Nov 26.
2
Management of follicular thyroid carcinoma.
Eur Thyroid J. 2024 Oct 16;13(5). doi: 10.1530/ETJ-24-0146. Print 2024 Oct 1.
3
Thermal ablation for Bethesda III and IV thyroid nodules: current diagnosis and management.
Ultrasonography. 2024 Nov;43(6):395-406. doi: 10.14366/usg.24083. Epub 2024 Aug 5.
5
Malignancy risk in Bethesda class IV thyroid nodules in an iodine deficient region.
Gland Surg. 2023 Jul 31;12(7):884-893. doi: 10.21037/gs-22-491. Epub 2023 Jul 4.
6
Current controversies in the management of patients with indeterminate thyroid nodules.
Saudi Med J. 2023 Jul;44(7):633-639. doi: 10.15537/smj.2023.44.7.2023-0049.
7
2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management.
Eur Thyroid J. 2023 Aug 14;12(5). doi: 10.1530/ETJ-23-0067. Print 2023 Oct 1.

本文引用的文献

1
Local molecular analysis of indeterminate thyroid nodules.
J Otolaryngol Head Neck Surg. 2015 Dec 1;44:52. doi: 10.1186/s40463-015-0106-2.
2
Effect of Gene Expression Classifier Molecular Testing on the Surgical Decision-Making Process for Patients With Thyroid Nodules.
JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1082-8. doi: 10.1001/jamaoto.2015.2708.
6
Voice outcomes following reoperative central neck dissection for recurrent/persistent thyroid cancer.
Laryngoscope. 2015 Nov;125(11):2621-5. doi: 10.1002/lary.25427. Epub 2015 Jul 7.
8
Incidental thyroid nodules and thyroid cancer: considerations before determining management.
JAMA Otolaryngol Head Neck Surg. 2015 Jun;141(6):566-72. doi: 10.1001/jamaoto.2015.0647.
9
A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology.
Ann Surg Oncol. 2015 May;22(5):1527-32. doi: 10.1245/s10434-014-4190-8. Epub 2014 Nov 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验